ArticleBMC ophthalmology2026
Electroretinographic patterns of retinitis pigmentosa in a Palestinian cohort: a clinical and functional characterization.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retinitis pigmentosa (RP) is a progressive rod–cone dystrophy and the most common inherited retinal disease worldwide. Electroretinography (ERG) provides an objective measure of retinal function and is essential for staging severity and guiding therapy. However, ERG data from Middle Eastern populations remain limited. In this cross-sectional study, 71 Palestinian patients with clinically confirmed RP underwent full-field ERG (ffERG) using ISCEV 2022 standards. Responses were classified into mild, moderate, and severe categories. Clinical variables including age, disease duration, best-corrected visual acuity (BCVA), and optical coherence tomography (OCT) findings were analyzed. Global ERG severity grading revealed severe impairment in 40.8% of patients; rod-specific DA 0.01 b-wave amplitude-based classification identified severe rod dysfunction in 32.4%. A strong negative cross-sectional correlation was observed between disease duration and DA 0.01 b-wave amplitude (r = − 0.95, p < 0.0001), consistent with cumulative rod photoreceptor loss over time; visual inspection of the scatter plot confirmed a monotonic relationship without evidence of outlier leverage. BCVA and OCT-derived central macular thickness showed no significant correlation with ERG parameters, underscoring the functional–structural dissociation in RP. Genetic testing (35.2% of cases) identified mutations in RPGR, RHO, USH2A, CRB1, and others; genotype–ERG observations are exploratory given small subgroup sizes. These findings establish baseline ERG profiles for Palestinian RP patients, support ERG-based severity grading, and emphasize the importance of electrophysiology for diagnosis, prognostic counseling, and therapeutic eligibility in underrepresented populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.